Two Sigma Securities’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Two Sigma Securities’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-77,568	Closed	-$27K	–	1087
2016 Q3	$27K	Buy	+77,568	New	+$27K	0.01%	592
2015 Q3	–	Sell	-15,654	Closed	-$27K	–	331
2015 Q2	$27K	Sell	15,654 -18,277	-54%	-$31.5K	0.05%	141
2015 Q1	$47K	Buy	+33,931	New	+$47K	0.05%	154

Two Sigma Securities's RXII Position: Q4 2016 in Review

Two Sigma Securities sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 77,568 shares — an estimated $27K sold.

Two Sigma Securities first reported a position in RXII in Q1 2015 and held it in 3 quarters. The position peaked at $47K in Q1 2015. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Two Sigma Securities reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Two Sigma Securities sold 77,568 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $27K.
Two Sigma Securities first reported a position in GALENA BIOPHARMA INC COM in Q1 2015 and held it in 3 quarters.
Two Sigma Securities's GALENA BIOPHARMA INC COM position peaked at $47K in Q1 2015.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Two Sigma Securities's 13F filing for Q4 2016, filed 14 Feb 2017.